4 completed. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow DA-8010 5mg: new trials by email Literature Review of DA-8010 5mg trials Research Report on DA-8010 5mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg - Healthy | Phase 1 | Completed | Dong-A ST Co., Ltd. | 37 | 2023-08-22 | 2024-01-25 |
| Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg - Healthy | Phase 1 | Completed | Dong-A ST Co., Ltd. | 18 | 2023-08-18 | 2024-01-25 |
| A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder DA-8010 Placebo, DA-8010 2.5mg, DA-8010 5mg - Overactive Bladder | Phase 3 | Completed | Dong-A ST Co., Ltd. | 607 | 2022-05-12 | 2024-06-26 |
| A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder DA-8010 Placebo, DA-8010 2.5mg, DA-8010 5mg - Overactive Bladder | Phase 2 | Completed | Dong-A ST Co., Ltd. | 306 | 2018-07-10 | 2020-02-07 |
Urinary Bladder, Overactive (2)
South Korea (4)